Matteo Massanova

Urologist | Robotic surgeon | Consultant at @MSEHospitals | Ex Fellow at @NHSGGC | CrossFit Enthusiast | Runner

[Matteo Massanova @MM_Urology]

@yang_kunlin @lee_c_zhao Don’t you taper the bowel?

[European Urology @EUplatinum]

🚨 NEW #PlatinumOpinion in European Urology by M. J. Roberts, @GGandaglia et al :

💡 Is extended pelvic lymph node dissection (ePLND) still justified in prostate cancer?

📉 No oncologic benefit in RCTs
⚠️ Up to 20% complication rate
🧬 PSMA PET reshapes staging

🔄 2024 EAU Guidelines update: reconsider routine ePLND.

🔗 https://t.co/XFczocASmF
#EAUGuidelines #ProstateCancer #UroOncology #ePLND #PSMAPET #urotwitter

[Urologic Oncology @UrolOncol]

📢Publication alert!

Highlights:
1⃣Across 11 trials, TMT was associated with lower OS and CSS than RC
2⃣RC should remain the standard of care for nonmetastatic MIBC
3⃣TMT remains a valid alternative for carefully selected and informed patients

🔗https://t.co/EERejp5J6l

[Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 @Cacciamani_MD]

Robotic-assisted cystectomy strategies:

🔬 21 expert surgeons analyzed
🤖 Demanding ileourethral approximation: 86%
🏗️ Studer/Bordeaux reconstructions popular
📉 Trendelenburg reduction: 43%

#Urology #RARC #Neobladder #Pub2Post

https://t.co/npaI3RhDtF

@MariaChiaraMCS @bernardorocco73 @Uroweb

[BJU International @BJUIjournal]

Real-world outcomes for high-risk non-muscle-invasive #BladderCancer: screened patients for the BRAVO trial
@S_Conroy91 @JimCatto

https://t.co/iGlTvitSyk

[BJS Open @BjsOpen]

Influence of a surgeon’s exposure to operating room turnover delays on patient outcomes
➡️https://t.co/Y0WLcHT3SZ

In this prospective study, a 3.3% (95% c.i. 0.6% to 5.6%) increase in the rate of major adverse events was observed when a surgeon experienced a delay in operating room scheduling or waiting time between two procedures exceeding 1 h. Optimizing operating room turnover to prevent delayed operations and waiting time is critical for patient safety.

👏👏👏Arnaud Pasquer, Quentin Cordier, Jean-Christophe Lifante, Gilles Poncet, Stéphanie Polazzi, Antoine Duclos
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @me4_so @BJSAcademy @BJSurgery @young_bjs @juliomayol @JJEarnshaw @OUPMedicine

[Boris Hadaschik @ProfHadaschik]

Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer - finally out. Early results from the PROBASE screening trial in younger men. Great team effort! https://t.co/xwLQu5eWui

[Matteo Massanova @MM_Urology]

@RafaelFCoelho2 Can we please watch full unedited video of this?

[Matteo Massanova @MM_Urology]

@Issarami I usually reserve this for patients who need palliation with short life expectancy.

[Matteo Massanova @MM_Urology]

@Issarami Totally agree, but all the headaches saved in the immediate post-operative recovery are often paid back on the mid-/long-term with multiple readmissions for dislodged stents, recurrent UTIs, stoma stenosis. Not to forget the need of keeping these patients on regular stent change.

[Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 @Cacciamani_MD]

💡This is the first report of vascularized #BladderTransplantation in a heart-beating, brain-dead human donor, with excellent vascular viability after reperfusion, and is a necessary #preclinical step before a first-in-human BT.

✅If clinically successful, BT could offer a bowel-free, more normal bladder substitute in selected patients with bladder failure.

https://t.co/ZZXfmoblRX

@uro_nima @USC_Urology @EUplatinum @Uroweb @AmerUrological

[Matteo Massanova @MM_Urology]

@UroNoel @GuysUrology @GSTTnhs @benchallacombe @cbrownurology @prokarurol Well done Jo, great milestone! Aim to 1000 now 😜

[Matteo Massanova @MM_Urology]

And should pN3 be taken off the TNM classification?

[Rami Issa @Issarami]

Is this the end of extended lymph node dissection in bladder cancer🤔

[Ashwin Sridhar @acesridhar]

If you are looking to train in robotic prostate surgery and bladder cancer surgery in a high volume pelvic cancer unit with a strong focus on education @SNathanUK @Jkurol @greglshaw @4urology @ZaferTandogdu @lambwben @KelkarUro @UroSplice @veerukasi https://t.co/onYr6CKD5N

[Matteo Massanova @MM_Urology]

Proud that the service we offer at @MSEHospitals has been publicised in the local newspaper. Gaining local awareness is important, so patients know that top class treatments can be delivered at their doorstep.
Thanks to my hardworking #team for the support.

#urology #essex

[Essex Echo @Essex_Echo]

4⃣ A surgeon based at Southend Hospital has become the first in the East of England to carry out a rare operation using a pioneering robotic device - By @Sophie_England_

https://t.co/ezemMIqbam

[Matteo Massanova @MM_Urology]

@lambwben @CancerNel @NHSBartsHealth @NHSHomerton @BHRUT_NHS Congratulations and well deserved

[Matteo Massanova @MM_Urology]

@Issarami @doculla @Uroweb @nairajesh @acesridhar Also, operating times in experienced surgeon are comparable in both approaches. So, yes, when the patient can go for either RARC or ORC, I do counsel about advantages of RARC 😂

[Matteo Massanova @MM_Urology]

@Issarami @doculla @Uroweb @nairajesh @acesridhar Unless patient/cancer characteristics do not allow a safe🤖 approach, RARC is first option IMHO. RAZOR, iROC don’t show any disadvantage for robotic vs open and rather quicker recovery and less DVT/PE or wound complications. Even cost has been shown to be not an issue anymore.

[Matteo Massanova @MM_Urology]

@acesridhar Thanks Ashwin, it means a lot coming from you 🙏🏻

[Toni Choueiri, MD @DrChoueiri]

It is this time of the year again: TOP 10 GU Oncology clinical papers/trials in 2022:

Some negative, some positive, but we learned from all!

Feel free to add more & retweet & tag anyone involved

This is not an exhaustive list!

@OncoAlert @danafarber

#OnwardFor2023